MSH2 and breast cancer: Taken together, loss of MSH2 alone was the most recurrent pattern of protein loss, being observed in 20 (25%) dMMR breast cancers (Supplementary Figure S3) and was related to shorter survival times (p = 0.04) (Supplementary Figure S4).